CRSP

Equibles Rating blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Buy Momentum Strong Sentiment Bearish Fundamentals Fair Quant / Vol Very High

Market backdrop VIX 16.9 · calm Equity put/call 0.86

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +7%

above

Price vs 50-day avg +11%

above

RSI (14) 61

neutral

MACD trend Positive

52-week position 44%

mid-range

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Strong

1-month return +15%

trailing

6-month return +5%

trailing

YTD return +13%

this year

Relative strength −2%

vs S&P · 6-mo

Sentiment

smart money

Bearish

Trend (MA cross) No cross

50d $53 › 200d $56 — 200d above 50d

Institutional flow Distributing

18 of 496 funds reported for Jun 30 · net -9.0K sh shares · +3 new

Insider flow Distributing

Net -$210.6K over 90 days · 100% sells

Short interest Rising

27.55% of float · ▲ +22.6% MoM · 16.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

496 holders — near 3-yr high, broad support

Squeeze score 85

high risk · 0–100

Fundamentals

Fair

Revenue growth +9170%

Y/Y

EPS growth −49%

Y/Y

Free cash flow $-345.9M

Balance sheet $347.6M

net cash

Quant / Vol

risk profile

Very High

Volatility 61%

annualized · 1-yr

Max drawdown −42%

past year

ATR 5.5%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Up next

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed May 4, 2026

Technicals

trend & momentum for long-term holders Buy

0 · 4 · 3

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+7% Bullish

Price vs 50-day avg

+11% Bullish

RSI (14)

61 Neutral

MACD trend

Positive Bullish

52-week position

44% Neutral

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Bearish · 3 of 6

Trend (MA cross) No cross

50d $53 › 200d $56 — 200d above 50d

Institutional flow Distributing

18 of 496 funds reported for Jun 30 · net -9.0K sh shares · +3 new

Insider flow Distributing

Net -$210.6K over 90 days · 100% sells

Short interest Rising

27.55% of float · ▲ +22.6% MoM · 16.4 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

496 holders — near 3-yr high, broad support

Price context

position in its 52-week range

52-wk low $44 Now $59 · 44% 52-wk high $78

vs 200-day avg +7% vs 50-day avg +11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from its earnings releases, calls, and filings

Metric	Latest	Period	YoY
patients received infusions of CASGEVY	64	full year 2025	—
people with SCD or TDT who initiated the treatment process with their first cell collection	147	full year 2025	—

Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
CRSP CRISPR Therapeutics AG this stock	$5.43B	+12.9%	+9169.8%	—	27.6%
ONC BeOne Medicines Ltd.	$437.67B	-0.6%	+22179.2%	890.7	0.1%
VRTX Vertex Pharmaceuticals Inc / Ma	$126.01B	+9.9%	+46.2%	29.5	1.8%
REGN Regeneron Pharmaceuticals, Inc.	$70.03B	-14.0%	+20.8%	16.3	3.2%
ARGX Argenx SE	$56.84B	+8.8%	—	—	2.4%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Reducing

Holders

499

% held: 83.4%
Reported: 18 of 496
Top holder: ARK Investment Management…

Held Float

View

Held by Funds

Fund positions

View

Short & Settlement

Short Interest Rising

Shares short

26.6M

Days to cover: 16.4d
Change: +4.9M sh

View

Short Volume

Short vol %

56%

As of: Jul 9, 2026

Short Total

View

Fails to Deliver

FTD shares

85.8K

Value: $4.2M
As of: Jun 11, 2026

View

Off-Exchange

Off-exchange %

53.7%

Week of: May 4, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$210.6K

Buyers / Sellers: 0 / 1

Buyers Sellers

View

Congressional Trades Sell

Member

Thomas Suozzi

Amount: $50.0K–$100.0K
Traded: Sep 20, 2021

View

Financials

Revenue (FY)

$3.5M

Net income (FY): $-581.6M
EPS diluted: $-6.47

View

Filings

SEC Filings

Latest

8-K

Filed: Jun 4, 2026
This year: 9

View

Proposed Sales

Value

$2.1M

Shares: 35.0K
Filed: Jan 22, 2026

View

Exempt Offerings

Offering

$1.0M

Filed: Apr 10, 2020

View

Performance

	5D	20D	120D	MTD	YTD
CRSP	+8.5%	+14.7%	+5.4%	+8.5%	+12.9%
SPY	-0.2%	+0.8%	+7.4%	-0.2%	+9.3%
vs SPY	+8.7%	+13.9%	-2.1%	+8.7%	+3.6%

Price & Indicators

Technicals

Key metrics

Versus peers

At a glance

Performance